| Gloria Laws, MD | |
|
301 4th St, Alexandria, LA 71301-8411 | |
| (318) 441-1041 | |
| Not Available |
| Full Name | Gloria Laws |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 301 4th St, Alexandria, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073905097 | NPI | - | NPPES |
| 337924 | Other | LA | FULL LOUISIANA MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 337924 (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | 327102 (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | 337924 (Louisiana) | Primary |
| Entity Name | Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20050610000177 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Vermilion Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215161096 PECOS PAC ID: 8820148554 Enrollment ID: O20090618000010 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20130515000072 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Jena Ess Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235544115 PECOS PAC ID: 7810116258 Enrollment ID: O20140916002675 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Jena Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144635020 PECOS PAC ID: 5294954533 Enrollment ID: O20140918000317 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Derussy Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306300900 PECOS PAC ID: 3870834641 Enrollment ID: O20190403002252 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Entity Name | Saline Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114481769 PECOS PAC ID: 1153662598 Enrollment ID: O20190411000953 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gloria Laws, MD 301 4th St Ste 30113, Alexandria, LA 71301-8420 Ph: () - | Gloria Laws, MD 301 4th St, Alexandria, LA 71301-8411 Ph: (318) 441-1041 |
News Archive
From holding your baby for the first time to bonding through breastfeeding, UC San Diego Health is committed to providing the highest quality of care and support for the best start to parenthood and life.
Higher health care utilization spending by physicians was not associated with better outcomes for hospitalized Medicare beneficiaries in a new article published online by JAMA Internal Medicine.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 6 days ago
Dr. Robert W Moore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Pecan Park Ave, Alexandria, LA 71303 Phone: 318-442-1002 Fax: 318-442-1008 | |
Robert Larimer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 4th Street, Rapides Regional Medical Center, Alexandria, LA 71301 Phone: 318-473-3000 | |
Ifedolapo Sulyman Olanrewaju, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-487-1122 Fax: 318-449-2320 | |
Michael Gurdon Buck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1587 N Bolton Ave, Suite 1100, Alexandria, LA 71303 Phone: 318-473-4500 Fax: 318-445-1509 | |
Dr. Margo Lashae Thomas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3335 Prescott Rd, Alexandria, LA 71301 Phone: 318-442-5758 | |
Ashley Billings, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6507 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-483-7774 | |
Jane Anjul Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Versailles Blvd Ste D, Alexandria, LA 71303 Phone: 318-528-3200 |